CSE/CURE.X (CSE/CURE.X)

Canadian Securities Exchange: CSE/CURE.X · CAD

CA$0.06

+0.00 (0.0%)· Recorded snapshot

Market cap	1.1M
Net income (ttm)	-2.3M
EPS (ttm)	-CA$0.11
Shares out	20.2M
Volume	28,000
Beta	3.64

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -2.3M
EPS (ttm): -CA$0.11
Market cap: 1.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-599.3

P25 n/aP50 n/aP75 n/a

ROIC-42.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/CURE.X indicators

Market & fundamental data

Available fields

129

Groups with data

Currency

CAD

Showing 129 of 129 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-23
Enterprise value	CAD 1.1M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2005
Industry	Biological Products, Except Diagnostic Substances
Is primary listing	Yes
ISIN number	CA09075T2065
Last earnings date	2025-11-26
Last refreshed	2026-10-30
Last stock split date	2024-10-28
Last stock split type	Reverse
Market cap	CAD 1.1M
Next earnings date	2026-11-23
Price	CAD 0.06
Price currency	CAD
SIC code	2836
Stock price date	2026-08-13
Symbol	cse/CURE.X
Website	https://www.biocuretech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-206.82%
FCF / EV yield	-4.43%
FCF yield	-4.49%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-18.26%
ROA (5Y)	-16.56%
ROCE	46.57%
ROE	-599.29%
ROIC	-42.53%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -300,946
EPS	CAD -0.11
FCF per share	CAD -0.00
Free cash flow	CAD -49,951
Net cash flow	CAD -49,951
Net income	CAD -2.3M
Operating income	CAD -300,946

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.03
Interest coverage	-30.35
Long-term assets	CAD 2
Long-term liabilities	CAD 0
Net cash (debt)	CAD -60,297
Net cash / market cap	-5.43%
Piotroski F-Score	1
Shareholders' equity	CAD -646,284
Tangible book value	CAD -646,284
Tangible book value per share	CAD -0.03
Total assets	CAD 32,913
Total cash	CAD 3,550
Total debt	CAD 63,847
Total liabilities	CAD 679,197
WACC	23.62%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 32,911
Current liabilities	CAD 679,197
Current ratio	0.05
Net working capital	CAD -585,989
Quick ratio	0.05
Working capital	CAD -646,286

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-85.83%
Shareholder yield	-85.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.19
1D price change	0%
1M price change	-15.38%
1M total return	-15.38%
1Y price change	10%
1Y return CAGR	10.01%
1Y total return	10%
20-day SMA	CAD 0.05
200-day SMA	CAD 0.22
3M price change	57.14%
3M total return	57.14%
3Y price change	-84.72%
3Y return CAGR	-46.53%
3Y total return	-84.72%
50-day SMA	CAD 0.06
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.24
52-week high date	2025-10-20
52-week low	CAD 0.03
52-week low date	2025-12-05
5Y price change	-96.41%
5Y return CAGR	-48.58%
5Y total return	-96.41%
6M price change	37.5%
6M total return	37.5%
All-time high	CAD 17.01
All-time high date	2018-02-01
All-time low	CAD 0.01
All-time low date	2024-11-27
Average true range (ATR)	CAD 0.01
Average volume	19.6K
Beta (1Y)	-2.31
Beta (2Y)	1.8
Beta (5Y)	3.64
Change from 52-week high	-77.08%
Change from 52-week low	83.33%
Change from all-time high	-99.68%
Change from all-time low	450%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 1,540
High price	CAD 0.06
Low price	CAD 0.06
Monthly RSI	39.73
Open price	CAD 0.06
Previous close	CAD 0.06
Price vs 150-day SMA	-70.54%
Price vs 20-day SMA	11.11%
Price vs 200-day SMA	-75.07%
Price vs 50-day SMA	-11.58%
Relative volume	1.43
RSI	50.44
Sharpe ratio	1.64
Sharpe ratio (3Y)	0.98
Sortino ratio	3.96
Sortino ratio (3Y)	2.29
Volume	28K
Weekly RSI	42.93
YTD price change	37.5%
YTD total return	37.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15.8M
Shares change (QoQ)	0%
Shares change (YoY)	85.83%
Shares held by insiders	19.28%
Shares outstanding	20.2M

Deeper analysis on CSE/CURE.X

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/CURE.X report

Is a complete CSE/CURE.X research report available?

No complete published report is available for cse/CURE.X (CSE/CURE.X) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/CURE.X (CSE/CURE.X)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/CURE.X

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/CURE.X indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/CURE.X

Frequently asked questions